what we do?

Rooted in science

sourced worldwide

LianBio is a biotechnology company focused on bringing paradigm-shifting medicines to patients.

arrow-btn

Scroll to see more

arrow-btn

intro

Our Mission

LianBio’s mission is to catalyze the development and accelerate availability of paradigm-shifting medicines to patients in China and major Asian markets through partnerships that provide access to the best science-driven therapeutic discoveries.

Learn More

Pipeline

Our Future

We are focused on building out a pipeline based on disease relevance to our target markets and the ability to impact patients with transformative mechanisms and precision-based therapeutics. We select programs with a strong scientific basis and clinical data and collaborate with world-class partners across a diverse array of therapeutic areas.

See All

Stay up to date

News & Events

June 2, 2021

Lyra Therapeutics and LianBio Announce Strategic Partnership and Exclusive License Agreement to Develop and Commercialize LYR-210 in Greater China and Other Asian Markets

arrow-btn

May 17, 2021

Landos Biopharma and LianBio Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Omilancor and NX-13 in Greater China and Select Asian Markets

arrow-btn

May 12, 2021

Nanobiotix Partners With LianBio to Develop and Commercialize Potential First-in-Class Radioenhancer NBTXR3 Across Tumore Types and Therapeutic Combinations in China and Other Asian Markets

arrow-btn

May 10, 2021

LianBio Appoints Yizhe Wang, Ph.D., as Chief Executive Officer

arrow-btn
See All

We are here for you

Contact Us

Email us directly:

IR@LianBio.com careers@lianbio.com

Office Addresses

Shanghai Office
9th Floor, Kerry Parkside, 1155 Fangdian Road
Unit 901-902
Shanghai, PRC 201204

New Jersey Office
103 Carnegie Center Drive
Suite 215
Princeton, NJ 08540